94 related articles for article (PubMed ID: 3125927)
21. [Pharmaceutical chemistry of sedato-hypnotics and anxiolytics].
Takácsné NK; Szász G
Acta Pharm Hung; 2004; 74(4):237-51. PubMed ID: 16316052
[TBL] [Abstract][Full Text] [Related]
22. [Respiratory dysfunction induced by drugs].
Kido M
Ryoikibetsu Shokogun Shirizu; 1994; (4):833-5. PubMed ID: 8007322
[No Abstract] [Full Text] [Related]
23. CNS-active drugs in aging population at high risk of cerebrovascular events: evidence from preclinical and clinical studies.
Zhao CS; Hartikainen S; Schallert T; Sivenius J; Jolkkonen J
Neurosci Biobehav Rev; 2008; 32(1):56-71. PubMed ID: 17599405
[TBL] [Abstract][Full Text] [Related]
24. When breastfeeding mothers need CNS-acting drugs.
Rubin ET; Lee A; Ito S
Can J Clin Pharmacol; 2004; 11(2):e257-66. PubMed ID: 15591613
[TBL] [Abstract][Full Text] [Related]
25. New developments in neuroscience.
Williams M
Curr Opin Investig Drugs; 2003 Jan; 4(1):26-7. PubMed ID: 12625023
[No Abstract] [Full Text] [Related]
26. Drug-induced stuttering.
Prescrire Int; 2000 Feb; 9(45):212. PubMed ID: 11503801
[TBL] [Abstract][Full Text] [Related]
27. Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care?
Hopkins MM; Martin PA
Expert Rev Neurother; 2006 Dec; 6(12):1765-7. PubMed ID: 17181421
[No Abstract] [Full Text] [Related]
28. Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney.
Unterbeck A
Drug Discov Today; 2005 Feb; 10(3):165-8. PubMed ID: 15708528
[No Abstract] [Full Text] [Related]
29. [Therapy of Alzheimer dementia. Current status and prospects].
Frölich L; Padberg F; Kratzsch T; Maurer K; Möller HJ; Hampel H
MMW Fortschr Med; 2000 Jun; 142(25):30-4. PubMed ID: 10920665
[TBL] [Abstract][Full Text] [Related]
30. Special considerations for medication use in children with developmental disabilities.
Rempel G; Coates J
Phys Med Rehabil Clin N Am; 1999 May; 10(2):493-509. PubMed ID: 10370943
[TBL] [Abstract][Full Text] [Related]
31. Ritual use of plants with possible action on the central nervous system by the Kraho Indians, Brazil.
Rodrigues E; Carlini EA
Phytother Res; 2005 Feb; 19(2):129-35. PubMed ID: 15852494
[TBL] [Abstract][Full Text] [Related]
32. The role of pharmacogenetics in treating central nervous system disorders.
Patnaik M; Renda MJ; Athanasiou MC; Reed CR
Exp Biol Med (Maywood); 2008 Dec; 233(12):1504-9. PubMed ID: 18849543
[TBL] [Abstract][Full Text] [Related]
33. Medication, learning disabilities and physical education.
French R; Jansma P
Am Correct Ther J; 1981; 35(1):26-30. PubMed ID: 6112870
[No Abstract] [Full Text] [Related]
34. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract.
Hiyama T; Yoshihara M; Tanaka S; Haruma K; Chayama K
J Gastroenterol Hepatol; 2009 Apr; 24(4):537-46. PubMed ID: 19220673
[TBL] [Abstract][Full Text] [Related]
35. How to use cerebral vasodilators and metabolic activators.
Isozumi K; Izumi Y
Tokai J Exp Clin Med; 1998 Oct; 23(4):187-92. PubMed ID: 10359509
[TBL] [Abstract][Full Text] [Related]
36. Melatonin in the Treatment of Primary Headache Disorders.
Gelfand AA
Headache; 2017 Jun; 57(6):848-849. PubMed ID: 28594124
[No Abstract] [Full Text] [Related]
37. New drugs and product approvals from 1999.
Gage TW; Taylor SE
Tex Dent J; 2000 Sep; 117(9):30-47. PubMed ID: 11857846
[No Abstract] [Full Text] [Related]
38. [Adverse effects of drugs on sexual behavior and fertility in males].
Przybilla B; Schill WB
Med Monatsschr Pharm; 1984 Jul; 7(7):197-208. PubMed ID: 6482827
[No Abstract] [Full Text] [Related]
39. Drugs and chemicals that act on the central nervous system: interpretation of experimental evidence.
Kellogg CK
Prog Clin Biol Res; 1985; 163C():147-53. PubMed ID: 3887421
[TBL] [Abstract][Full Text] [Related]
40. Potential anti-dementia agents in traditional Chinese medicine.
Li XJ; Zhang HY
Nat Prod Commun; 2009 Jun; 4(6):877-86. PubMed ID: 19634342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
